We have developed new asymmetric allylation methods
for the selective generation of chiral amines
utilizing environmentally benign indium and bismnuth
catalysts. We are targeting cancer and other
autoimmune diseases through the development of novel
inhibitors for histone deacetylases. These enzymes
are responsible for epigenetic regulation of tumor
suppressors and other genes. Please explore our site
to find out more about who we are and what we do.